News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,986 Results
Type
Article (42065)
Company Profile (303)
Press Release (685605)
Multimedia
Podcasts (90)
Webinars (20)
Section
Business (206524)
Career Advice (2060)
Deals (35792)
Drug Delivery (116)
Drug Development (81955)
Employer Resources (174)
FDA (16500)
Job Trends (15100)
News (349196)
Policy (32997)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2618)
Accelerated approval (31)
Adcomms (27)
Allergies (139)
Alliances (50286)
ALS (171)
Alzheimer's disease (1685)
Antibody-drug conjugate (ADC) (309)
Approvals (16759)
Artificial intelligence (516)
Autoimmune disease (151)
Automation (39)
Bankruptcy (366)
Best Places to Work (11735)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (193)
Bladder cancer (159)
Brain cancer (55)
Breast cancer (635)
Cancer (4793)
Cardiovascular disease (397)
Career advice (1739)
Career pathing (35)
CAR-T (284)
CDC (46)
Celiac Disease (2)
Cell therapy (753)
Cervical cancer (36)
Clinical research (69903)
Collaboration (1718)
Company closure (4)
Compensation (1149)
Complete response letters (53)
COVID-19 (2767)
CRISPR (89)
C-suite (842)
Cystic fibrosis (145)
Data (6186)
Decentralized trials (2)
Denatured (32)
Depression (139)
Diabetes (498)
Diagnostics (6729)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (252)
Drug pricing (190)
Drug shortages (28)
Duchenne muscular dystrophy (228)
Earnings (90321)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (118182)
Executive appointments (988)
FDA (19600)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1490)
Gene editing (197)
Generative AI (43)
Gene therapy (600)
GLP-1 (978)
Government (4710)
Grass and pollen (6)
Guidances (383)
Healthcare (18991)
HIV (57)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (253)
Immuno-oncology (56)
Indications (105)
Infectious disease (3031)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (244)
Interviews (321)
IPO (16713)
IRA (53)
Job creations (3703)
Job search strategy (1458)
JPM (57)
Kidney cancer (15)
Labor market (83)
Layoffs (566)
Leadership (30)
Legal (8008)
Liver cancer (92)
Longevity (14)
Lung cancer (644)
Lymphoma (372)
Machine learning (43)
Management (59)
Manufacturing (805)
MASH (162)
Medical device (13845)
Medtech (13898)
Mergers & acquisitions (20146)
Metabolic disorders (1265)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (320)
Neuropsychiatric disorders (92)
Neuroscience (2927)
Neurotech (1)
NextGen: Class of 2026 (6602)
Non-profit (4543)
Now hiring (65)
Obesity (594)
Opinion (269)
Ovarian cancer (165)
Pain (200)
Pancreatic cancer (225)
Parkinson's disease (284)
Partnered (36)
Patents (490)
Patient recruitment (476)
Peanut (56)
People (59522)
Pharmaceutical (67)
Pharmacy benefit managers (29)
Phase 1 (21784)
Phase 2 (30784)
Phase 3 (22924)
Pipeline (5142)
Policy (285)
Postmarket research (2579)
Preclinical (9250)
Press Release (65)
Prostate cancer (235)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (833)
Real estate (6057)
Recruiting (70)
Regulatory (24625)
Reports (51)
Research institute (2426)
Resumes & cover letters (358)
Rett syndrome (28)
RNA editing (19)
RSV (76)
Schizophrenia (151)
Series A (251)
Series B (191)
Service/supplier (14)
Sickle cell disease (95)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (41)
Startups (3704)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (87)
The Weekly (56)
Vaccines (1002)
Venture capital (88)
Weight loss (384)
Women's health (88)
Worklife (18)
Date
Today (93)
Last 7 days (574)
Last 30 days (2067)
Last 365 days (30203)
2026 (2953)
2025 (30547)
2024 (35528)
2023 (40373)
2022 (51540)
2021 (56078)
2020 (54483)
2019 (46996)
2018 (35357)
2017 (32433)
2016 (31828)
2015 (37914)
2014 (31609)
2013 (26664)
2012 (28919)
2011 (29564)
2010 (27616)
Location
Africa (754)
Alabama (84)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39721)
Australia (6513)
California (11262)
Canada (3262)
China (1099)
Colorado (476)
Connecticut (475)
Delaware (334)
Europe (86062)
Florida (1670)
Georgia (356)
Hawaii (3)
Idaho (63)
Illinois (863)
India (64)
Indiana (520)
Iowa (23)
Japan (423)
Kansas (130)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1379)
Massachusetts (8069)
Michigan (321)
Minnesota (628)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (79)
New Jersey (2978)
New Mexico (29)
New York (2964)
North Carolina (1470)
North Dakota (9)
Northern California (5488)
Ohio (333)
Oklahoma (21)
Oregon (42)
Pennsylvania (2262)
Puerto Rico (22)
Rhode Island (47)
South America (1121)
South Carolina (65)
South Dakota (1)
Southern California (4376)
Tennessee (173)
Texas (1750)
United States (39940)
Utah (336)
Vermont (1)
Virginia (260)
Washington D.C. (82)
Washington State (936)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
727,986 Results for "scale biosciences inc aka scalebio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
January 12, 2026
·
3 min read
Vaccines
Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets
Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all suffering revenue hits to their vaccine programs.
November 7, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale
December 22, 2025
·
3 min read
Press Releases
MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
Mustard-derived organic TerraSanteTM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies; Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; and Significant soil health benefit when applied in combination with the current grower standard program.
December 10, 2025
·
6 min read
Press Releases
Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
December 12, 2025
·
4 min read
Press Releases
NARMAFOTINIB Large-Scale Manufactre Complete
January 23, 2026
·
3 min read
Press Releases
SpectronRx Begins Commercial-Scale Production of High-Purity Actinium-225, Strengthening Global Supply for Cancer Therapies
Indiana-based radiopharmaceutical contract development and manufacturing organization producing Ac-225 at a scale
October 30, 2025
·
1 min read
Press Releases
10x Genomics to Acquire Scale Biosciences
August 8, 2025
·
5 min read
Press Releases
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale
Exosomes Produced in the Liquid Media of the BioHarvest Unique Large-Scale Bioreactors Add Potential New Revenue Stream from Products and CDMO Opportunities
September 10, 2025
·
4 min read
Press Releases
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
January 9, 2026
·
3 min read
1 of 72,799
Next
